Skip to content

13F-HR filed by Broadfin Capital, LLC

Broadfin Capital, LLC filed this 13F-HR for the quarter ended 2017-03-31, filed 2017-05-15, with 55 holding rows worth $825,621,000.

Accession
0001511901-17-000002
Filed
2017-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2017

A holdings report, 55 entries on the cover page, a total value of $825,621,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $825,621,000 with VALUE read as thousands by filing date, 13F file number 028-14251. The quarter's positions are built on this report. The resolved quarter.

Other managers

  • included managerBroadfin Healthcare Master Fund Ltd 028-14254

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
HORIZON PHARMA PLCG4617B105SHS5,664,219$83,717,000thousands by filing date
HERON THERAPEUTICS INC427746102COM4,947,403$74,211,000thousands by filing date
SPDR SER TR78464A870S&P BIOTECH1,000,000$69,340,000thousands by filing dateput
RETROPHIN INC761299106COM2,892,178$53,390,000thousands by filing date
AVADEL PHARMACEUTICALS, PLC05337M104COMMON STOCK-FO4,394,464$42,538,000thousands by filing date
SOCIETAL CDMO INC75629F109COM3,100,086$27,095,000thousands by filing date
ANGIODYNAMICS INC03475V101COM1,465,452$25,426,000thousands by filing date
LA JOLLA PHARMACEUTICAL CO503459604COM PAR $.0001 2782,887$23,369,000thousands by filing date
IGNYTA INC451731103COM2,637,346$22,681,000thousands by filing date
ENDO INTL PLCG30401106SHS2,000,000$22,320,000thousands by filing datecall
ANTARES PHARMA INC036642106COM7,642,206$21,704,000thousands by filing date
ENDO INTL PLCG30401106SHS1,883,738$21,023,000thousands by filing date
NOVELION THERAPEUTICS INC67001K202COM NEW1,948,554$20,927,000thousands by filing date
ARATANA THERAPEUTICS INC03874P101COM3,695,442$19,586,000thousands by filing date
PROGENICS PHARMACEUTICALS IN743187106COM1,998,531$18,866,000thousands by filing date
Lion Biotechnologies53619R102COM2,509,059$18,692,000thousands by filing date
CATALYST PHARMACEUTICALS INC14888U101COM8,200,000$15,990,000thousands by filing date
VERACYTE INC COM92337F107Stock1,648,566$15,134,000thousands by filing date
TELIGENT INC NEW87960W104COM1,931,711$15,087,000thousands by filing date
HORIZON PHARMA PLCG4617B105SHS1,000,000$14,780,000thousands by filing datecall
STRONGBRIDGE BIOPHARMA PLCG85347105SHS USD2,981,706$14,163,000thousands by filing date
ADVAXIS INC007624208COM NEW1,519,259$12,412,000thousands by filing date
ENDOLOGIX INC29266S106COM1,669,020$12,084,000thousands by filing date
CORIUM INTL INC21887L107COM2,787,121$11,650,000thousands by filing date
ARALEZ PHARMACEUTICALS INC03852X100COM5,191,590$11,110,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM2,090,801$10,872,000thousands by filing date
MEDICINES CO584688105COM215,077$10,517,000thousands by filing date
BIODELIVERY SCIENCES INTL IN09060J106COM5,398,794$10,258,000thousands by filing date
IDERA PHARMACEUTICALS INC45168K306COM3,852,945$9,517,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW2,833,649$9,068,000thousands by filing date
DURECT CORP266605104COM8,506,229$8,932,000thousands by filing date
SEASPINE HLDGS CORP81255T108COM1,099,807$8,633,000thousands by filing date
Egalet Corporation28226BAB0Note 5.50% 4/1/2010,000,000$8,238,000thousands by filing date
BARD C R INC067383109COM27,300$6,785,000thousands by filing date
ADMA BIOLOGICS INC000899104COM1,028,672$5,020,000thousands by filing date
CIDARA THERAPEUTICS INC COM NEW171757107Stock562,875$4,390,000thousands by filing date
NEXVET BIOPHARMA PLCG6503X109ORD SHS1,127,200$4,385,000thousands by filing date
PARATEK PHARMACEUTICALS INC699374302Equity223,862$4,309,000thousands by filing date
MEDIWOUND LTDM68830104ORD SHS633,102$4,178,000thousands by filing date
DEXCOM INC COM252131107Stock49,300$4,177,000thousands by filing date
SCYNEXIS INC COM NEW811292101Common Stock1,477,273$4,077,000thousands by filing date
PERNIX THERAPEUTICS HLDGS IN71426VAK4DBCV 4.250 4/015,500,000$4,049,000thousands by filing date
JUNO THERAPEUTICS INC48205A109COM175,700$3,899,000thousands by filing date
ONCOMED PHARMACEUTICALS INC COM68234X102Stock300,000$2,763,000thousands by filing datecall
CONTRAFECT CORP212326102COM1,429,109$2,572,000thousands by filing date
PROGENICS PHARMACEUTICALS IN743187106COM250,000$2,360,000thousands by filing datecall
AVIRAGEN THERAPEUTICS INC053761102COM3,179,226$2,072,000thousands by filing date
Alcobra LtdM2239P109SHS1,216,643$1,387,000thousands by filing date
COGENTIX MED INC COM19243A104Stock753,773$1,357,000thousands by filing date
AVINGER INC053734109COM500,000$950,000thousands by filing date
AEVI GENOMIC MEDICINE INC00835P105COM500,000$930,000thousands by filing datecall
WINDTREE THERAPEUTICS INC97382D105COM777,797$887,000thousands by filing date
DEXTERA SURGICAL INC COM252366109CS599,440$635,000thousands by filing date
STRATA SKIN SCIENCES INC86272A107COM961,422$582,000thousands by filing date
ALPHATEC HLDGS INC02081G201COM NEW226,006$527,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001511901-17-000002this filing2017-05-15acceptance time not in the bulk data set